These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12620298)

  • 21. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary report.
    Case DC
    Blood; 1982 May; 59(5):934-7. PubMed ID: 6803856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
    Pilorge S; Park S; Dreyfus F; Bouscary D; Tamburini J
    Leuk Lymphoma; 2010 Dec; 51(12):2288-90. PubMed ID: 20929331
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
    Rigual D; Qiu J; Fenstermaker RA; Fabiano AJ
    Clin Neurol Neurosurg; 2013 Jun; 115(6):823-6. PubMed ID: 22902079
    [No Abstract]   [Full Text] [Related]  

  • 25. Alkylating agents for Waldenstrom's macroglobulinaemia.
    Yang K; Tan J; Wu T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006719. PubMed ID: 19160296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of bone marrow response in Waldenström's macroglobulinemia.
    Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
    Kawano N; Ikeda N; Yoshida S; Sugio Y; Yamashita K; Uezono S; Hayashi T; Hara S; Makino S; Shimoda K; Ueda A
    Int J Hematol; 2010 Sep; 92(2):391-7. PubMed ID: 20686877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of lymphoma with respect to pathologic classification: updates and controversies].
    Zhu J; Song YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009
    [No Abstract]   [Full Text] [Related]  

  • 29. 45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California.
    Clin Lymphoma; 2003 Dec; 4(3):141-8. PubMed ID: 14715094
    [No Abstract]   [Full Text] [Related]  

  • 30. [MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia].
    Izumi S; Kimura K; Takeda Y; Tsukamoto S; Yamazaki M; Mishina T; Nagai Y; Takaishi K; Nagao Y; Oshima-Hasegawa N; Mitsukawa S; Mimura N; Takeuchi M; Ohwada C; Iseki T; Ota S; Nakaseko C; Sakaida E
    Rinsho Ketsueki; 2018; 59(12):2600-2605. PubMed ID: 30626796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
    Owen RG
    Expert Opin Pharmacother; 2001 Jun; 2(6):945-52. PubMed ID: 11585010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
    Paschal BR
    Leuk Lymphoma; 2003 Apr; 44(4):731-3. PubMed ID: 12769354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment options in Waldenstrom's macroglobulinemia.
    Björkholm M
    Clin Lymphoma; 2004 Dec; 5(3):155-62. PubMed ID: 15636690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
    Lazarevic VLj; Liljeholm M; Forsberg K; Söderberg S; Wahlin A
    Leuk Lymphoma; 2008 Jun; 49(6):1209-11. PubMed ID: 18452089
    [No Abstract]   [Full Text] [Related]  

  • 35. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
    Kim HD; Shin KC; Cho HS; Kim MK; Lee KH; Hyun MS
    J Korean Med Sci; 2007 Dec; 22(6):1079-81. PubMed ID: 18162727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Waldenström's macroglobulinemia.
    McKenna JA
    Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How I treat Waldenström macroglobulinemia.
    Treon SP
    Blood; 2015 Aug; 126(6):721-32. PubMed ID: 26002963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
    Gavriatopoulou M; Kastritis E; Kyrtsonis MC; Vassilakopoulos TP; Roussou M; Fotiou D; Migkou M; Mpakiri M; Tasidou A; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Jun; 58(6):1506-1508. PubMed ID: 27724158
    [No Abstract]   [Full Text] [Related]  

  • 40. [Osteonecrosis developing after rituximab-containing chemotherapy for Waldenström macroglobulinemia].
    Nakamura F; Hirai R; Higo T; Togano T; Sekine R
    Rinsho Ketsueki; 2018; 59(3):305-309. PubMed ID: 29618689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.